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06jectives. This study was undertaken to tat the hypothesis 
that the risk of prioperative wdiac events is mot simply deter. 
mhted by the presence of myocardium at risk, but is dhwtly 
t&ted to the errtent of myocardium at risk as ret:oeted in 
thallhuu-201 myocatdiel imagtng. 
Bec&groemt. The risk or pertoperative cardiac events in pe- 
tietus undergoing nomno%u surgery htu been related to the 
pressttce of trausient defecta on dipyrtdamcle thtinm-201 q yo- 
car&d imaghtg, retRcttog jcopatdtzed viable myecardium. 
Dletiedt. The study cohort consisteu of 231 consecutive ps- 
tiei& who onclement ttoacardiw sargery and tmd a greogere- 
tive dtpyrtdantote thattiom40l imegiug study, Bat&b with 
MSEUIPT remastructiott or bypam constituted 1he largest 
sargketsubgroup (a = 140). Forthalllom.ZOI lmeging d&a, each 
of three pInttar pto&timu was divided into three segments (total 
ulttesrgma$)andeechsegmeulwasiuterpFetedaswrtnaloc 
shewingatmudeutorttseddeRct.TheabttityoEcliiand 
thatttua.u)I tmagiug date IO predkt prtogcretive cardim event.9 
The ability of preoperative dipyridamule thallium-201 myo- 
cardial imaging to predict periopotative cardiac events in 
patients undergoing ooncmdiac surgery has been established 
by several investigations (I-9). Each of these studies found 
that the risk of cardiac events is related ID the presence of 
transient defects, reflecting jeopardized viable myocardium. 
prior data (I) have suggested that the probability of cardiac 
events otttong patients with coronary artery disease is re- 
lated not only to presence or absence of transient defects but 
also to the extent of myocardium at risk. When making 
recommendations for periogetative care in patients who are 
scheduled for noncardiac surgery and have thallium-201 
imaging studies showing transient defects, clinicians may 
base their decision in part on the extent of the thallium 
abnormalities. However, it is unclear whether such an 
approach is valid. This study was undertaken lo examine the 
relation between the riskof pcrioperntive cardiac events and 
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the extent 01 myocardium at risk by thnllium-201 imaging in 
patients undergoing noncardiac surged. 
Methods 
Study patieots. A consecutive series of 231 patients un- 
dergoing noncardiac surgery who had dipyridamole thallium- 
201 studies performed within I month before operation 
between February 19% through July 1390 formed the study 
cohort. Patients undergoing vascular reconstruction or by- 
pass constituted the largest surgical subgroup (n = 140). The 
types of noncardiac surgery and other patient charactctistics 
are listed in Table 1. All prior myocardiaJ infarctions oc- 
curred 26 months before noncardiac surgery. 
Contemporaneously with the study cohort, an additional 
92 patients had a dipytidamole thallium-201 procedure per- 
formed with a listed indication of preoperative risk strati& 
cation but never underwent contemplated noncardiac SUT- 
gety. Clinical characteristics of these patients are listed in 
Table 2. When compared with the study cohort, this group 
did not differ significantly in age, gender or frequency of 
transient defects, fixed defects only or normal study results. 
However, the mean number of transient defects was greater 
in the group that never underwent surgery than in the study 

thallium-201 activity on the delayed images compared wth 
the early post-stress images (IO). 
Perioperative and postoperative care. Patient manage- 
ment was entirely dicta:ed by treating physicians. who wre 
aware of the results of the preoperative thallium-201 study. 
In general, patients with evidence of ischemia on thallium. 
201 imagin& received antianginal medications during and 
after operation and had intraoperative hemodyoatnic moni- 
toting with a right heart catheter. However, no attempt was 
made ta standardize care. Of particular note, only four 
patients underwent coronary revascularizaticn before non- 
cardiac surgery. Each patient had transient defects present 
on dipyridamole thallium-201 imaging, involving one to three 
myocardial segments. 
Follow-up data. Patient data during the hospital stay and 
for 30 days after the noncardiac operation were collected by 
a research nurse without knowledge of thallium-201 imaging 
results. Cardiac events were identified by the research nurse 
and confirmed by the study physician, still without knowl- 
edge of the thallium-201 results. They included cardiac 
death, nonfatal myocardial infarction and unstable angina. 
Cardiac death was defined by death due to myocardial 
infarction, congestive heart failure o’ primary cardiac arrest. 
Myocardia) infarction was cont?rrned by electrocardio- 
graphic and enzymatic data. Unstable angina was defined as 
rest angina associated with transient ischemic ST segment 
changes. 
Stuflstlcal analysis. Values are presented as mean 
value + SD. Patient variables evaluated for the ability to 
predict pertoperative cardiac events are listed in Table I. 
The univariate relation of each variable to perioperative 
cardiac events was examined by using chi-square analysis 
for categoric vatiablos and at test or Wilcoxon rank-sum test 
for continuous variables. A significance level of 0.05 was 
used. To compare the relative prognostic value of patient 
variables, stepwise multivtiatc logistic regression analysis 
was used (BMDPLR, revised 1987). AnaIysis was performed 
separately for cardiac events, defined as all evenls as well as 
only the “hard” end points of cardiac death or nonfatal 
myocardial infarclion. 
Results 
Hea~udynamic response. In response to dipyridernnle. 
heart rate increased f?om 71 + 12 beatslmin to a peak of 
95 t- It3 beats/mitt (p < O.WI). Systolic and diastolic blood 
pressure decreased from 135 2 18 to 126 ? 23 mm Hg (p < 
O.CiN) and from 75 + 18 to 68 ? 19 mm Hg (p < O.OOl), 
respectively. 
Cardiac evettfs. Petioperdtive cardiac events occurred in 
19 patients: cardiic death in 5, nonftttal tnyocardial infarc- 
tion in 7 and unstable angina in 7. All cardiac events 
occurred during the hospital stay; none occurred between 
the time of discharge rum the 30-day follow-up. 
Cardiac death and wnfatal myacardid infarction. The 
meau number of myocardial segments with transient 
@tre i. Comparison of the number of myccwdial segments with 
transient thallium-201 defects among patients without any p=Soptr- 
ativc cardiac event ww. patients developing perioperative cardiac 
death or nonfatal myccardial infaxtionW and patients developing 
any periopentive cardiac event. Ckd symb& represent individual 
patients. Open 5ymb& represent mean values. BE&& indicate 
! SD. 
thallium-201 defects and the frequency of transient defects. 
combined transient and Cxed defects and history ofdiabetes 
meltitus were greater in patients who developed periopem- 
tive cardiac death or nonfatal myocardial infarction than in 
patients who did not (Table I). No other patient variable had 
any significant univariate relation to these “hard” car&c 
end points. Figure 2 compares the number of segments with 
transient defects among patients who developed periopern- 
tive cardiac death or myocardiai infarction versus those of 
patients who did not devetop a cardiac event. Using mutti- 
variate logistic regression analysis. the number of myocar- 
dial segments with transient thallium-201 defects was the 
most powerful predictor of periopemtive cardiac death or 
nonfatal myocardii infarction (p < O.ooO5) (Table 3). Only a 
history of diabetes meRitus added any signiftcant predictive 
value (p < 0.05) to the regression txdel (Table 3). No other 
tested variable had any signiticant predictive value. The 
probability of periopemtive cardiac death or nonfalal myo- 
cardial infarction is displayed as a function of the number of 
transient thallium-201 defects and history of diabetes melli- 
tus in Figure 3. 
AS cardiac events. The number of myocardird segments 
with transient thallium-201 defects and the frrquettcy of 
transient thallium-201 defects, combined transient and fixed 
dcfccts, histoty of diabetes mellitus and calcium channel 
blacker use were greater among patients who developed any 
perioperative cardiac event (cardiac death, nonfatal myocar- 
dial infarction or unstable angina) then in patients who did 
not (Table I). Figure 2 compares the number of segments 
with transient defects among patients who developed any 
pertoperative cardiac event with that in those who did not 
develop a cardiac event. By multivariate analysis, the num- 
ber of myocardial segments with transient thallium-201 de- 
fee ts (p < O.MHtl) was the mosr powerful predictor of overall 
Table 3. Multivariate Predictors of Perioperative Cardiac Death or Nonfa!al Myocardial Infarction 
Step 2: After No. of 
Segmeots With Transient 
Steo 0: Before Variables Tl-201 Defects a-d Hx 
&red lnla Model Diabetes MeUitus Entered 
cbi- 
No. of segments with fransient ‘IKXIL defeclr 
Presence of rnnsient TI-%I defects 
presence of tranricnt and fixed TI-201 defects 
fix diabetes mellit>~s 
No. xeements with tixed TIJOI defects 
Hx mngula pecraris 
Hx prior MI
Nitrate use 
Smoker 
Age 
Q WBVLS 
Nonsinur rhythm 
Presence of only fixed TI-201 defects 
ST depression ot rest 
HX SlrOkC 
Hx hypwcholesterokmia 
Bundle branch block 
Gender 
Hx hypertension 
Family fix CAD 
HX CHF 
Hx CABGIPTCA 
14.76 O.wOI 
9.58 iw2 
7.4i O.C% 
2.Fd 0.1 
2.61 0.11 
2.23 0.14 
2.17 0.14 
1.91 0.16 
1.73 0.18 
I.44 0.23 
1.23 0.27 
0.8s 0.36 
0.74 0.39 
0.55 cl.21 
0.43 0.51 
0.39 0.53 
0.39 0.53 
0.34 0.56 
0.29 0.59 
0.27 0.60 
0.27 0.60 
0.23 0.63 
0.10 0.75 
0.06 0.W 
Chi-Square p value 
(12.33) 
1.19 
1.83 
(4.26) 
I.95 
2.09 
1.99 
0.76 
2.35 
to.Kw 
0.3. 
0.18 
10.039) 
0.16 
0.15 
II.16 
0.38 
0.13 
0.51 
0.31 
0.51 
0.35 
V.47 
0.47 
0.57 
0.67 
0.44 
0.86 
0.30 
0.97 
0.39 
0.75 
0.67 
0.96 
0.43 
1.02 
0.44 
0.81 
0.53 
0.54 
il.33 
0.18 
0.61 
0.03 
I.09 
0.w 
0.73 
0.10 
0.18 
0.02 
Beta-blocker use 0.03 0.95 0.58 0 4s 
Values in parenthercs indicale significance(p < 0.05). TI-201 = thallium-201: other abbwiaticns ar in T: :K 
cardiac events. Calcium channel blocker use (p < 0.05) and 
history of diabetes mellitus (p < 0.05) were the only other 
variables to provide any significant predictive value for 
Figure 3. Pmbability ofpxioperative cardiac death (CD) or nonfatal 
myocardial inftvction (NFMI) as a function of the number of 
myocardial segments with transient thallium-201 defects and the 
presence or absence of diabetes mellitus. 
2 3 4 6 7 
overall periopcmtive cardiac events. No other patient vari- 
able had any significant multivariate predictive value. 
Nonsurgical thsllhxn.2M imaging group. Among the 92 
patients who did not undergo contemplated noncardiac 
surgery although they were referred far preoperative dipyr- 
idamole thallium-201 imaging performed contemporaneously 
with the study cohort, the mean number of myoeardial 
segments with transient defects (1.0 * 1.6) (Table 2) was 
greater than that of patients undergoing noncardiac surgery 
who did not have a p&operative cardiac event (0.5 -C 1.D: 
p < 0.005) but wss less than that of patients who developed 
any cardixc event (2.2 + 1.8: p < 0.01) (Table 1). 
Discussion 
Ear studies (l-9) have clearly established that the pres- 
ence of transient defects on dipyridamole thallium-201 myo- 
cardial imaging identifies a group of patients who are at high 
risk for perioperativc cardiac events when undergoing on- 
cardiac surgery. Aithongh one recent report (13) described 
no relation between thallium-201 results and perioperative 
outcome, this finding is in contrast IO the much larger prior 
Tabk 4. Periopcmtive Risk Subgroups Based cm the Number of 
Segments With Truwent Thallium-ZDI Defects and a Kiswy uf 
Diabetes Meilirus 
Risk W;th TD NFhfl W’;lh TD NFMl 
LOW 0 <5% “-2 SS% 
Medium l-2 105c2o% 3-4 ltPz-2a% 
High 23 >2S% s5 >zsz 
CD = cardiac death: Hx = history of: NFMI = nonfatal myocardial 
mfarclion; TD = Innrvnt thallem-201 dcfecls. 
body of data (l-9). Possible seleclion bias and a paucity of 
hard cardiac events have been suggested as an explanation 
for their discordant observations (14). Our study confirms a 
strong relation between thallium-201 imaging results and 
perioperatiw cardiac risk. However, it shows that the risk of 
important periopcrative cardiac events in patients undergo- 
ing noncardiac surgery is related not only to tbc present? 
of transient thallium-201 defects but also to the extent of 
jeopardized viable myocardium as reflected in the number 
of myocardial segments with transient defects. This finding 
is consistent with previous observations (1) in other groups 
of patients with coronary artery disease in whom the prob- 
ability of developing a cardiac event is a function of the 
extent of myocardium at risk as reAected in the number of 
myocardird segments with transient thallium-201 defects. In 
addition, we found that a history of diabetes mellitus had a 
significant influence on p&operative cardiac risk (Table 4). 
Unlike other studies (43, our investigation did not demon- 
strate any other clinical variable to be significantly related to 
perioperative cardiac death or myocardial infarction. The 
only other clinical variabIe to have any prognostic value for 
overall cardiac events was the use of calcium channel 
blockers at the time of operation. However, whether this 
observation indicates that calcium channel blocker usage 
actually adversely affects perioperative outcome or rather is 
simdv a marker of a submoup of oatients with more severe 
underlying disease is u&no&. _ 
Prior studIs. Lette et al. (6) found that the risk of 
pcrioperative cardiac death or myocnrdial infarction was 
related to scintigraphic indexes of the extent and severity of 
reversible defects on dipyridamole thallium-201 imaging in 
patients undergoing major general or vascular surgery, al- 
though only 21 patients with reversible defects were evalu- 
ated. Similarlv. Lane et al. (8) observed that oeriooemtive . 
risk was related not only to the presence of hipyidamole 
thallium-201 transient defects but also to the number of 
myocardial segments with reversible defects. Finally, Levin- 
son et al. (12) reported that periopentive risk was greatest in 
patients with transient defects seen in at least 4 of IS 
myocardial segments, two of three views or two of three 
cmxmary territories. Unlike our study, these previous inves- 
&dons either did not evaluate the extent of myocardiam at 
risk as a conlinuous variable or did not use multivariate 
analysis to compare the relative prognostic value with other 
clinical and scmtigraphic predictors. Nevertheless, each of 
these findings is consistent with our observations of a direct 
relation hetween the extent d myocardium at rixk and 
,>crioperative cardiac risk. Our study is the first to show that 
extent of jeopardized viable myocardium on dipyridamole- 
thallium-Xtl imaging appears to be the best predictor of 
perioperative cardiac events. 
Type of surgery. We found that risk of periupcrative 
cardiac events was not related to the type of noncaxd& 
surgery that the patient was undergoing. There was no 
significant difference in cardiac event rate among the diiTer- 
ent surgical subgroups (Table I). One might have expected a 
higher frequency of cardiac events among patierns undergo- 
ing vascular surgery because of an expectedhigher incidence 
of coexisting coronary artery disease. Although there was a 
slight trend toward a higher frequency of cardiac events 
amo:e patients undergoing vajclrlar <%) compared with 
nonvascular 6%) surgery. this did not reach statisticat 
significance CTa5le I). A miscellaneous group of patients 
undergoing “nonmajor” nonvascular surgery had no cardiac 
events. raising the question of whether any risk stratification 
with thallium-201 imaging is necessary in this subgroup. 
However, the number of patients in this subgroup was too 
small for any definitive conclusions to be drawn. 
&imitations of current study. Only those patients in 
whom dipyridamole thallium-201 imaging was clinically re- 
quested by a treating physician formed the study cohort. 
This factor would tend to cause a selection bias favoring 
pdients at higher risk of having significant coronary disease 
or cardiac events or undergoing higher risk surgery. At the 
same time. the thallium-201 imaging results were available to 
treating physicians at a time when the clinical implications of 
transient thallium-201 defects were already known or p- 
sumed. This is likely to have led to a selection bias of !he 
study cohort favoring low risk patients because scinrigra thic 
evidence ofjeapardized viable myoeardium in geneml led to 
greater clinical and hemodynamic monitoring and intensive 
medical therapy periopemtively and may have led lo avoid- 
ance of noncardiic surgery altogether. As evidence of this 
possible bias, patients referred for preoperative dipyr- 
idamole thallium-201 ima&g who did not undergo contem- 
plated noncardiac surgery had a greater mean number of 
transient defects. Finally, some (albeit few) patients with 
transient defects underwent coronary revasctdarization be- 
fore noncardiac surgery. However, despite this likely elim- 
ination of the highest risk patients from our study cohort, the 
presence and extent of transient thallium-201 defects re- 
mained very powerful predictors of cardiac events. It is 
probable that the prognostic value of thallium-201 imaging 
would be even greater had the study cohorl been nonselec- 
tive.. 
Clinical imp%eatiens. Our study suggests that &bough 
transient defects on preoperative thallium-201 studies in 
patients undergoing noncardiac surgery are associated with 
an increased risk of perioperative cardiac events, the rela- 
tion between transient defects and pcriaperative risk should 
be viewed as a cantinuum, not categorically. Periopetative 
cardiac risk increases as a function of the extent of jcopar- 
dized viable myocardium. We also found that the predictive 
vahte of thallium-201 imaging was significantly improved by 
knowing whether or not a patient has diabetes mellitus. 
Patients can thus be classified into low, medium and high 
risk grmtps on the basis of the number of segmenis with 
transient thallium-201 defects and a history of diabetes 
mellitus (Table 4). Patients at low risk for petioperative 
cardiac events would be utdikely to benefit from invasive 
interventions such as catheterization or revascularization 
before planned noncardiac surgery, although it would be 
d~:sirable to have patients with any degree of myocardium at 
risk or with known coronary artery disease placed on some 
antianginal therapy petioperatively. In contrast, patients at 
high risk for perioperative cardiac events probably shatdd 
undergo cardiac catheterization before roncardiac surgery 
to determine their candidacy for revasculariration. In pa- 
tients with an intermediate risk, either aggressive perioper- 
ative medical treatment or an invasive approach to deter- 
mine the need for revasctdarization would be appropriate. In 
all cases, preoperative evaluation and perioperative care 
decisions need to be individualized as much as possible, 
taking into consideration all available data, including the 
urgency of the planned noncardiac surgery because delaying 
such surgery carries its own risks. 
Cottclnsions. Pertoperative risk of cardiac events for pa- 
tients undergoing noncrrdiac surgery appears to be best 
related to the extent of ayocardium at risk as reflected on 
dipyridamole-thallium-201 imaging. It is recommended that 
quantification of the extent of transient defects be part of the 
routine evaluation of preoperative myocardial perfu+m 
imaging studies. 
Appendix 
The probability of perioperative cardiac death or nonfatal myocw 
dial infarction was calculated from the logistic regression model: 
e” 
Robabilily = z, 
where x = 0.66 (y) + 1.36 (z) - 4.27 and y = number of 
myocardial segments with transient defects, z = I (with 
history of diabetes mellitus) and z = 0 (without history of 
diabetes mellitus). 
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